相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Population pharmacokinetics analysis of camidanlumab tesirine in patients with relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma
Marie Toukam et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2023)
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study
Mehdi Hamadani et al.
Lancet Haematology (2021)
Preliminary Results of a Phase 2 Study of Camidanlumab Tesirine (Cami), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Hodgkin Lymphoma
Alex F. Herrera et al.
BLOOD (2020)
Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management
Stephen M. Ansell
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms
Manli Jiang et al.
EXPERT REVIEW OF HEMATOLOGY (2017)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2017)
Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma
M. Gupta et al.
ANNALS OF ONCOLOGY (2016)
ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies
Michael J. Flynn et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Clinical significance of serum soluble interleukin-2 receptor-α in extranodal natural killer/T-cell lymphoma (ENKTL): a predictive biomarker for treatment efficacy and valuable prognostic factor
Wang Liang et al.
MEDICAL ONCOLOGY (2013)
Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens
Naoe Goto et al.
ANNALS OF HEMATOLOGY (2012)
Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial
Andrew P. Ambrosy et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies
Camilla A. Lindqvist et al.
IMMUNOLOGY (2010)
Liver enzyme alteration: a guide for clinicians
EG Giannini et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
分享论文
